Wells Fargo & Company Incyte Corp Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Incyte Corp stock. As of the latest transaction made, Wells Fargo & Company holds 107,970 shares of INCY stock, worth $7.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,970

Previous 102,093 5.76%

Holding current value

$7.47 Million

Previous $6.19 Million 15.32%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$57.33 - $68.61 $336,928 - $403,220	5,877 Added 5.76%	107,970 $7.14 Million
Q2 2024 Aug 13, 2024	SELL	$51.18 - $63.75 $167,819 - $209,036	-3,279 Reduced 3.11%	102,093 $6.19 Million
Q1 2024 May 10, 2024	BUY	$56.55 - $66.59 $580,655 - $683,746	10,268 Added 10.8%	105,372 $6 Million
Q4 2023 Feb 09, 2024	SELL	$52.16 - $64.19 $4.8 Million - $5.9 Million	-91,935 Reduced 49.15%	95,104 $5.97 Million
Q3 2023 Nov 13, 2023	SELL	$57.77 - $65.93 $2.32 Million - $2.65 Million	-40,242 Reduced 17.71%	187,039 $10.8 Million
Q2 2023 Aug 15, 2023	BUY	$60.95 - $75.51 $3.16 Million - $3.92 Million	51,882 Added 29.58%	227,281 $14.1 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $3.92 Million - $4.8 Million	55,777 Added 46.63%	175,399 $12.7 Million
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $571,030 - $714,935	-8,500 Reduced 6.63%	119,622 $9.61 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $752,466 - $942,118	-11,370 Reduced 8.15%	128,122 $8.54 Million
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $5.37 Million - $6.75 Million	-81,182 Reduced 36.79%	139,492 $10.6 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $64,105 - $77,398	971 Added 0.44%	220,674 $17.5 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $6.24 Million - $7.3 Million	-98,458 Reduced 30.95%	219,703 $16.1 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $4.99 Million - $6.11 Million	-72,715 Reduced 18.6%	318,161 $21.9 Million
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $8.07 Million - $8.84 Million	101,012 Added 34.85%	390,876 $32.9 Million
Q1 2021 May 13, 2021	SELL	$76.02 - $100.5 $2.67 Million - $3.53 Million	-35,155 Reduced 10.82%	289,864 $23.6 Million
Q4 2020 Feb 09, 2021	SELL	$80.74 - $97.7 $19.8 Million - $23.9 Million	-245,024 Reduced 42.98%	325,019 $28.3 Million
Q3 2020 Nov 05, 2020	BUY	$85.07 - $109.69 $2.25 Million - $2.9 Million	26,439 Added 4.86%	570,043 $51.2 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $13.4 Million - $19.6 Million	180,122 Added 49.55%	543,604 $56.5 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $23 Million - $31.2 Million	363,482 New	363,482 $26.6 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Incyte Corp Transaction History